Adverse drug reactions related to use of interferon beta-1A, interferon beta-1B and glatiramer for multiple sclerosis treatment (2012)
- Authors:
- Autor USP: KANO, EUNICE KAZUE - FCF
- Unidade: FCF
- Subjects: ESCLEROSE MÚLTIPLA; INTERFERON TIPO I
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Brazilian Journal of Pharmaceutical Sciences
- ISSN: 1984-8250
- Volume/Número/Paginação/Ano: v. 48, suppl. 1, p. 5 res. FCF005, 2012
- Conference titles: Pharmaceutical Science and Technology Meeting
-
ABNT
VILLA, Kamilla Fernandes e RIBEIRO, Adalton Guimarães e KANO, Eunice Kazue. Adverse drug reactions related to use of interferon beta-1A, interferon beta-1B and glatiramer for multiple sclerosis treatment. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 27 abr. 2024. , 2012 -
APA
Villa, K. F., Ribeiro, A. G., & Kano, E. K. (2012). Adverse drug reactions related to use of interferon beta-1A, interferon beta-1B and glatiramer for multiple sclerosis treatment. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. -
NLM
Villa KF, Ribeiro AG, Kano EK. Adverse drug reactions related to use of interferon beta-1A, interferon beta-1B and glatiramer for multiple sclerosis treatment. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 5 res. FCF005.[citado 2024 abr. 27 ] -
Vancouver
Villa KF, Ribeiro AG, Kano EK. Adverse drug reactions related to use of interferon beta-1A, interferon beta-1B and glatiramer for multiple sclerosis treatment. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 5 res. FCF005.[citado 2024 abr. 27 ] - Osteonecrosis of jaw in use of bisphosphonates
- Assessment of safety and effectivity associated to oseltamivir therapy
- New oral anticoagulants: what do their adverse drug reactions reports suggest?
- Avaliação biofarmacêutica de formulações contendo cefadroxil: estudo in vitro e in vivo (bioequivalência)
- Analysis of adverse drug reaction profile of immunobiological TNF-α inhibitors: a pharmacovigilance overview
- Rituximab and tocilizumab: comparison of profiles of adverse drug reaction
- Use of in silico study to evaluate the effects of different sampling schedules on the assessment of bioequivalence of drugs with long half-life
- Study of drug-related adverse effects of levonorgestrel intrauterine device
- Risk of neuropsychiatric adverse drug reaction associated to use of varenicline tartrate
- Adverse drug reactions profile of new drugs for Hepatits C
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
